Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis

Siyuan Ma, Shuji Ogino, Princy Parsana, Reiko Nishihara, Zhirong Qian, Jeanne Shen, Kosuke Mima, Yohei Masugi, Yin Cao, Jonathan A. Nowak, Kaori Shima, Yujin Hoshida, Edward L. Giovannucci, Manish K. Gala, Andrew T. Chan, Charles S. Fuchs, Giovanni Parmigiani, Curtis Huttenhower, Levi Waldron

Research output: Contribution to journalArticle

Abstract

Background: Previous approaches to defining subtypes of colorectal carcinoma (CRC) and other cancers based on transcriptomes have assumed the existence of discrete subtypes. We analyze gene expression patterns of colorectal tumors from a large number of patients to test this assumption and propose an approach to identify potentially a continuum of subtypes that are present across independent studies and cohorts. Results: We examine the assumption of discrete CRC subtypes by integrating 18 published gene expression datasets and > 3700 patients, and contrary to previous reports, find no evidence to support the existence of discrete transcriptional subtypes. Using a meta-analysis approach to identify co-expression patterns present in multiple datasets, we identify and define robust, continuously varying subtype scores to represent CRC transcriptomes. The subtype scores are consistent with established subtypes (including microsatellite instability and previously proposed discrete transcriptome subtypes), but better represent overall transcriptional activity than do discrete subtypes. The scores are also better predictors of tumor location, stage, grade, and times of disease-free survival than discrete subtypes. Gene set enrichment analysis reveals that the subtype scores characterize T-cell function, inflammation response, and cyclin-dependent kinase regulation of DNA replication. Conclusions: We find no evidence to support discrete subtypes of the CRC transcriptome and instead propose two validated scores to better characterize a continuity of CRC transcriptomes.

Original languageEnglish (US)
Article number142
JournalGenome Biology
Volume19
Issue number1
DOIs
StatePublished - Sep 25 2018

Fingerprint

meta-analysis
colorectal neoplasms
Transcriptome
transcriptome
Meta-Analysis
Colorectal Neoplasms
cancer
tumor
gene expression
DNA
Microsatellite Instability
neoplasms
cyclin-dependent kinase
Cyclin-Dependent Kinases
gene
Gene Expression Profiling
DNA replication
DNA Replication
Disease-Free Survival
Neoplasms

Keywords

  • Colon cancer
  • Progression
  • Transcriptional profiling
  • Tumor

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Genetics
  • Cell Biology

Cite this

Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis. / Ma, Siyuan; Ogino, Shuji; Parsana, Princy; Nishihara, Reiko; Qian, Zhirong; Shen, Jeanne; Mima, Kosuke; Masugi, Yohei; Cao, Yin; Nowak, Jonathan A.; Shima, Kaori; Hoshida, Yujin; Giovannucci, Edward L.; Gala, Manish K.; Chan, Andrew T.; Fuchs, Charles S.; Parmigiani, Giovanni; Huttenhower, Curtis; Waldron, Levi.

In: Genome Biology, Vol. 19, No. 1, 142, 25.09.2018.

Research output: Contribution to journalArticle

Ma, S, Ogino, S, Parsana, P, Nishihara, R, Qian, Z, Shen, J, Mima, K, Masugi, Y, Cao, Y, Nowak, JA, Shima, K, Hoshida, Y, Giovannucci, EL, Gala, MK, Chan, AT, Fuchs, CS, Parmigiani, G, Huttenhower, C & Waldron, L 2018, 'Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis', Genome Biology, vol. 19, no. 1, 142. https://doi.org/10.1186/s13059-018-1511-4
Ma, Siyuan ; Ogino, Shuji ; Parsana, Princy ; Nishihara, Reiko ; Qian, Zhirong ; Shen, Jeanne ; Mima, Kosuke ; Masugi, Yohei ; Cao, Yin ; Nowak, Jonathan A. ; Shima, Kaori ; Hoshida, Yujin ; Giovannucci, Edward L. ; Gala, Manish K. ; Chan, Andrew T. ; Fuchs, Charles S. ; Parmigiani, Giovanni ; Huttenhower, Curtis ; Waldron, Levi. / Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis. In: Genome Biology. 2018 ; Vol. 19, No. 1.
@article{538386eb1c624a97a8cd679e918944c9,
title = "Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis",
abstract = "Background: Previous approaches to defining subtypes of colorectal carcinoma (CRC) and other cancers based on transcriptomes have assumed the existence of discrete subtypes. We analyze gene expression patterns of colorectal tumors from a large number of patients to test this assumption and propose an approach to identify potentially a continuum of subtypes that are present across independent studies and cohorts. Results: We examine the assumption of discrete CRC subtypes by integrating 18 published gene expression datasets and > 3700 patients, and contrary to previous reports, find no evidence to support the existence of discrete transcriptional subtypes. Using a meta-analysis approach to identify co-expression patterns present in multiple datasets, we identify and define robust, continuously varying subtype scores to represent CRC transcriptomes. The subtype scores are consistent with established subtypes (including microsatellite instability and previously proposed discrete transcriptome subtypes), but better represent overall transcriptional activity than do discrete subtypes. The scores are also better predictors of tumor location, stage, grade, and times of disease-free survival than discrete subtypes. Gene set enrichment analysis reveals that the subtype scores characterize T-cell function, inflammation response, and cyclin-dependent kinase regulation of DNA replication. Conclusions: We find no evidence to support discrete subtypes of the CRC transcriptome and instead propose two validated scores to better characterize a continuity of CRC transcriptomes.",
keywords = "Colon cancer, Progression, Transcriptional profiling, Tumor",
author = "Siyuan Ma and Shuji Ogino and Princy Parsana and Reiko Nishihara and Zhirong Qian and Jeanne Shen and Kosuke Mima and Yohei Masugi and Yin Cao and Nowak, {Jonathan A.} and Kaori Shima and Yujin Hoshida and Giovannucci, {Edward L.} and Gala, {Manish K.} and Chan, {Andrew T.} and Fuchs, {Charles S.} and Giovanni Parmigiani and Curtis Huttenhower and Levi Waldron",
year = "2018",
month = "9",
day = "25",
doi = "10.1186/s13059-018-1511-4",
language = "English (US)",
volume = "19",
journal = "Genome Biology",
issn = "1474-7596",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Continuity of transcriptomes among colorectal cancer subtypes based on meta-analysis

AU - Ma, Siyuan

AU - Ogino, Shuji

AU - Parsana, Princy

AU - Nishihara, Reiko

AU - Qian, Zhirong

AU - Shen, Jeanne

AU - Mima, Kosuke

AU - Masugi, Yohei

AU - Cao, Yin

AU - Nowak, Jonathan A.

AU - Shima, Kaori

AU - Hoshida, Yujin

AU - Giovannucci, Edward L.

AU - Gala, Manish K.

AU - Chan, Andrew T.

AU - Fuchs, Charles S.

AU - Parmigiani, Giovanni

AU - Huttenhower, Curtis

AU - Waldron, Levi

PY - 2018/9/25

Y1 - 2018/9/25

N2 - Background: Previous approaches to defining subtypes of colorectal carcinoma (CRC) and other cancers based on transcriptomes have assumed the existence of discrete subtypes. We analyze gene expression patterns of colorectal tumors from a large number of patients to test this assumption and propose an approach to identify potentially a continuum of subtypes that are present across independent studies and cohorts. Results: We examine the assumption of discrete CRC subtypes by integrating 18 published gene expression datasets and > 3700 patients, and contrary to previous reports, find no evidence to support the existence of discrete transcriptional subtypes. Using a meta-analysis approach to identify co-expression patterns present in multiple datasets, we identify and define robust, continuously varying subtype scores to represent CRC transcriptomes. The subtype scores are consistent with established subtypes (including microsatellite instability and previously proposed discrete transcriptome subtypes), but better represent overall transcriptional activity than do discrete subtypes. The scores are also better predictors of tumor location, stage, grade, and times of disease-free survival than discrete subtypes. Gene set enrichment analysis reveals that the subtype scores characterize T-cell function, inflammation response, and cyclin-dependent kinase regulation of DNA replication. Conclusions: We find no evidence to support discrete subtypes of the CRC transcriptome and instead propose two validated scores to better characterize a continuity of CRC transcriptomes.

AB - Background: Previous approaches to defining subtypes of colorectal carcinoma (CRC) and other cancers based on transcriptomes have assumed the existence of discrete subtypes. We analyze gene expression patterns of colorectal tumors from a large number of patients to test this assumption and propose an approach to identify potentially a continuum of subtypes that are present across independent studies and cohorts. Results: We examine the assumption of discrete CRC subtypes by integrating 18 published gene expression datasets and > 3700 patients, and contrary to previous reports, find no evidence to support the existence of discrete transcriptional subtypes. Using a meta-analysis approach to identify co-expression patterns present in multiple datasets, we identify and define robust, continuously varying subtype scores to represent CRC transcriptomes. The subtype scores are consistent with established subtypes (including microsatellite instability and previously proposed discrete transcriptome subtypes), but better represent overall transcriptional activity than do discrete subtypes. The scores are also better predictors of tumor location, stage, grade, and times of disease-free survival than discrete subtypes. Gene set enrichment analysis reveals that the subtype scores characterize T-cell function, inflammation response, and cyclin-dependent kinase regulation of DNA replication. Conclusions: We find no evidence to support discrete subtypes of the CRC transcriptome and instead propose two validated scores to better characterize a continuity of CRC transcriptomes.

KW - Colon cancer

KW - Progression

KW - Transcriptional profiling

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=85054014576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054014576&partnerID=8YFLogxK

U2 - 10.1186/s13059-018-1511-4

DO - 10.1186/s13059-018-1511-4

M3 - Article

VL - 19

JO - Genome Biology

JF - Genome Biology

SN - 1474-7596

IS - 1

M1 - 142

ER -